Talis Biomedical Corp
NASDAQ:TLIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
US |
|
BiVictriX Therapeutics PLC
LSE:BVX
|
UK |
Shareholder Yield
Current shareholder yield for TLIS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
TLIS Price
Talis Biomedical Corp
| Average Annual Return | -56.48% |
| Standard Deviation of Annual Returns | 44.68% |
| Max Drawdown | -99% |
| Market Capitalization | 5.2m USD |
| Shares Outstanding | 1 820 000 |
| Percentage of Shares Shorted | 1.54% |
TLIS Return Decomposition
Main factors of price return
Stock Splits
TLIS's latest stock split occurred on Jul 6, 2023
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, TLIS traded at 0.4981 per share. Afterward, the share price was about 7.36.
The adjusted shares began trading on Jul 6, 2023. This was the only stock split in TLIS's history.
